Gladiator Therapeutics is a leading research and development company specializing in Far Infrared Technology. The company is dedicated to offering new devices for medical conditions with few treatment options, that can benefit from the cellular regeneration properties of our patented technology.
In 2019, Gladiator Therapeutics began research to develop medical devices utilizing a unique patented Far Infrared technology. Our partner, Dr. Albert Wey is the inventor of FIR-based Reaction Barrier Reduction (RBR) technology. He discovered that FIR (far-infrared) in a 3 – 16 micron wavelength range may be absorbed by most molecules, facilitating the absorption of energy and the elimination of waste. This allows cells to function more normally, achieving homeostasis.